Investing in healthcare stocks can be a hedge against market volatility. Some pharmaceutical and biotech stocks behave more like growth stocks, providing a balance. Novo Nordisk and AbbVie are good long-term investments due to their growth potential and low valuations. Novo Nordisk dominates in GLP-1 drugs, with sales expected to rise. AbbVie is a strong performer with blockbuster drugs and a high dividend yield.

Novo Nordisk and AbbVie offer solid investment opportunities. Novo Nordisk is a leader in GLP-1 drugs, while AbbVie has a strong track record and dividend yield. Both stocks are relatively cheap with significant growth potential. Analysts predict AbbVie’s stock price to rise by 11% in the next 12 months. Invest wisely for long-term gains.

Consider the advice of the Motley Fool Stock Advisor team when investing. Novo Nordisk may not be on their top 10 list, but the 10 recommended stocks have shown significant returns in the past. Stock Advisor’s average return is 886%, outperforming the S&P 500. Join an investing community for individual investors to maximize your investment potential.

Read more at Yahoo Finance: Got $500? 2 Pharma Stocks to Buy and Hold Forever.